A review of JADER and FAERS databases identified common adverse effects for 3 antibody-drug conjugates with the same type of payload.

The findings suggest that the HER2DX assay could help clinicians decide on the appropriate use of chemotherapy in older patients, study researchers wrote.

In just the past 8 years since we launched this report, the 5-year survival rate has gone from 18% to nearly 30%,” said Harold Wimmer, President and CEO of the American Lung Association.

Study reveals 5.05 percent of individuals carry pathogenic/likely pathogenic variants in in large, unselected U.S. population.

Consistently reaching guidelines at moderate levels over three decades associated with significant reduction in digestive cancer risk.